Regonat Regorafenib 40 mg Tablets

Regorafenib 40 mg Tablets, a Tyrosine kinase inhibitor, is utilized in the treatment of colorectal cancer /cancer of colon and rectum. \n \nFor optimal benefits, Regorafenib 40 mg Tablets should be taken with food, consistently at the same time each day. The doctor determines the necessary dosage and frequency based on the patient's specific condition, which may change over time. Strict adherence to the doctor's instructions is crucial to avoid serious side effects. While the benefits may take weeks or months to become apparent, discontinuation should only occur under the doctor's guidance.